Cardiac gene therapy represents a cutting-edge approach in the realm of cardiovascular medicine, holding immense promise for the treatment of various heart-related conditions. This innovative therapeutic strategy involves the introduction of specific genes into the heart with the aim of correcting or modulating genetic defects, enhancing myocardial function, and mitigating the progression of cardiac diseases. By leveraging the potential of gene delivery systems, researchers are exploring avenues to address conditions such as heart failure, hypertrophic cardiomyopathy, and other genetic cardiovascular disorders. The evolving field of cardiac gene therapy signifies a paradigm shift, offering hope for more targeted and personalized interventions in the quest for improved heart health. As scientists continue to unravel the complexities of cardiac genetics, the potential for groundbreaking advancements in treating cardiovascular diseases through gene-based approaches remains a captivating area of exploration and development.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom